Improving cancer treatment with radiation therapy
Core C: Radiosensitization Core
This study is looking at ways to make radiation therapy work better for cancer patients by testing different treatments that can help tumors respond more effectively to the radiation.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10917041 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of radiation therapy for cancer by evaluating how different therapeutic agents can sensitize tumors to radiation. The team will use advanced techniques to irradiate cultured cells and animal models, developing precise treatment plans for targeting tumors. By utilizing imaging technologies, they aim to optimize the combination of therapies to improve patient outcomes. The project also involves collaboration with various resources at the Rogel Cancer Center to ensure comprehensive support for the research activities.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with specific types of cancer who are undergoing or considering radiation therapy as part of their treatment plan.
Not a fit: Patients with non-cancerous conditions or those not receiving radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments that improve survival rates and reduce side effects for patients undergoing radiation therapy.
How similar studies have performed: Previous research has shown promising results in enhancing radiation therapy effectiveness through sensitization strategies, indicating a strong potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Rehemtulla, Alnawaz — University of Michigan at Ann Arbor
- Study coordinator: Rehemtulla, Alnawaz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.